NO964825D0 - Ny doseringsform av hydroksokoboltamin og dens anvendelse ved cyanidforgiftning - Google Patents

Ny doseringsform av hydroksokoboltamin og dens anvendelse ved cyanidforgiftning

Info

Publication number
NO964825D0
NO964825D0 NO964825A NO964825A NO964825D0 NO 964825 D0 NO964825 D0 NO 964825D0 NO 964825 A NO964825 A NO 964825A NO 964825 A NO964825 A NO 964825A NO 964825 D0 NO964825 D0 NO 964825D0
Authority
NO
Norway
Prior art keywords
hydroxocobaltamine
dosage form
new dosage
cyanide poisoning
poisoning
Prior art date
Application number
NO964825A
Other languages
English (en)
Other versions
NO315495B1 (no
NO964825L (no
Inventor
Gerard Pouchol
Yves Bonhomme
Marie-Laura Poulain
Michel Durand
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO964825D0 publication Critical patent/NO964825D0/no
Publication of NO964825L publication Critical patent/NO964825L/no
Publication of NO315495B1 publication Critical patent/NO315495B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19964825A 1995-11-15 1996-11-14 Farmasöytiske preparater som inneholder hydroksokoboltamin, fremgangsmåterfor fremstilling derav, förstehjelpssett for behandling avcyanidforgiftning oganvendelse derav til fremstilling av et medikament NO315495B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513512A FR2740973B1 (fr) 1995-11-15 1995-11-15 Nouvelle forme d'administration de l'hydroxocobalamine et son utilisation dans les intoxications par les cyanures

Publications (3)

Publication Number Publication Date
NO964825D0 true NO964825D0 (no) 1996-11-14
NO964825L NO964825L (no) 1997-05-16
NO315495B1 NO315495B1 (no) 2003-09-15

Family

ID=9484577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964825A NO315495B1 (no) 1995-11-15 1996-11-14 Farmasöytiske preparater som inneholder hydroksokoboltamin, fremgangsmåterfor fremstilling derav, förstehjelpssett for behandling avcyanidforgiftning oganvendelse derav til fremstilling av et medikament

Country Status (10)

Country Link
US (1) US5834448A (no)
EP (1) EP0775485B1 (no)
JP (1) JP3699223B2 (no)
AU (1) AU720219B2 (no)
DE (1) DE69619767T2 (no)
DK (1) DK0775485T3 (no)
ES (1) ES2171591T3 (no)
FR (1) FR2740973B1 (no)
IS (1) IS1880B (no)
NO (1) NO315495B1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3948026B2 (ja) * 1993-07-19 2007-07-25 東レ株式会社 脳細胞保護剤
AR022986A1 (es) * 1996-08-12 2002-09-04 Gist Brocades Bv Produccion y uso de composiciones que comprenden concentraciones altas de actividad de vitamina b12
AU2004236603B2 (en) * 2003-05-07 2006-12-07 Eisai R & D Management Co., Ltd. Freeze-dried preparation containing methylcobalamin and process for producing the same
US9585908B1 (en) * 2010-11-08 2017-03-07 Chromaceutical Advanced Technologies, Inc. Collyrium composition and method of using same
US9757354B2 (en) * 2015-06-08 2017-09-12 Regents Of The University Of Minnesota Therapeutic formulations and methods
US11925623B2 (en) 2020-07-21 2024-03-12 Regents Of The University Of Minnesota Methods for the treatment of conditions related to hydrogen sulfide
TWI818601B (zh) 2021-10-29 2023-10-11 原創生醫股份有限公司 用於上呼吸道給藥之組成物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788780A (fr) * 1971-09-21 1973-01-02 Rolland Sa A Procede pour le diagnostic de l'hypercyanurie
FR2534809B1 (fr) * 1982-10-26 1985-06-28 Roussel Uclaf Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci

Also Published As

Publication number Publication date
DE69619767D1 (de) 2002-04-18
IS4387A (is) 1997-05-16
AU720219B2 (en) 2000-05-25
EP0775485A1 (en) 1997-05-28
DE69619767T2 (de) 2002-10-10
EP0775485B1 (en) 2002-03-13
IS1880B (is) 2003-08-15
AU7172096A (en) 1997-05-22
DK0775485T3 (da) 2002-05-06
ES2171591T3 (es) 2002-09-16
JP3699223B2 (ja) 2005-09-28
FR2740973B1 (fr) 1998-02-06
US5834448A (en) 1998-11-10
NO315495B1 (no) 2003-09-15
JPH09136837A (ja) 1997-05-27
FR2740973A1 (fr) 1997-05-16
NO964825L (no) 1997-05-16

Similar Documents

Publication Publication Date Title
NO933240D0 (no) Anordning ved og fremstilling av tannb!rste
ZA963287B (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
NO975309D0 (no) Anvendelse av rivavirin og alfa-interferon til behandling av hepatitt C
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
DE69415157D1 (de) Elektrochirurgischer prozessor und anwendung
ID23687A (id) Metode penggunaan penghambat siklooksigenase-2 dalam pencegahan penyakit kardiovaskuler
DK0745396T3 (da) Blodpumpe og anvendelse deraf
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
DE69620270T2 (de) Backfett und dessen Verwendung
NO961346L (no) Benzonitriler og benzofluorider
NO951825D0 (no) Vannbasert hårbehandlingspreparat og anvendelse av dette
PT898566E (pt) Benzilaminas substituidas e sua utilizacao no tratamento da depressao
NO964825L (no) Ny doseringsform av hydroksokoboltamin og dens anvendelse ved cyanidforgiftning
ID19147A (id) Ksilanase dan pemakaiannya
DE69620243T2 (de) Haupt- und nebenstromfilter
DE69608182T2 (de) Wasserstoffspeichernde Legierung und Elektrode daraus
ID28797A (id) Tioredoksin dan pemrosesan biji-bijian
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
BR9606978A (pt) Anticorpos monoclonais antiidiótipos (ab2) e usos dos mesmos
GB9514816D0 (en) Substances and their medical use
NO981719D0 (no) Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b
FI971086A (fi) Kinaasia sitova proteiini ja sen käyttö
FR2722198B1 (fr) 1derives de silylmethyl-anilines, le2fabrication, et leur utilisation co
LV10916A (lv) Metoklopramida lietosana kardalgijas arstesana
KR960033565U (ko) 지압 및 쑥뜸 겸용 지압구

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SERB, BE

MK1K Patent expired